Remove FDA Remove Presentation Remove Public Health
article thumbnail

Public Health Product Hops

Bill of Health

Yet Dmitry Karshtedt held otherwise at the ASLME Health Law Professor’s Conference in Atlanta, GA in 2017. On a panel together, we each presented on topics relating to product hopping, but from very different perspectives. But perhaps other forms of public health benefit would outweigh these harms?

article thumbnail

Safety First: Potential Heart Health Risks of Microdosing

Bill of Health

In fact, a recent FDA regulatory forum toxicology expert review article has suggested that a medication’s 5HT 2B binding affinity (Ki) was considered a better predictor of VHD risk than measures of functional activity such as EC50.

FDA 354
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Five Opportunities to Use the Law to Address Persistent OUD Treatment Gaps 

Bill of Health

health care system, but that are especially present for behavioral health needs like substance use, and are exacerbated by other challenges related to stigma, lack of employment, and fragmented or nonexistent care coordination. This reality reflects structural, policy, and legal misalignments common to the entire U.S.

article thumbnail

The Supreme Court Threatens to Undermine Vaccination Decisions Entrusted to the States

Bill of Health

Newsom a legal principle that threatens to upend over a century of legal precedent recognizing the authority of state governments to ensure public health by mandating vaccines. Presently, among the fifty U.S. In 2021, the Supreme Court articulated in Tandon v.

COVID-19 162
article thumbnail

Unlocking the mRNA Platform Technology: Walking the Talk with Investment Protection

Bill of Health

However, rewards from these government investments are going back into the hands of pharma corporations and shareholders, with little thought given to public needs. Recent Research on Public Funding of mRNA Technology The first of the two new articles is an in-depth empirical study of U.S.

article thumbnail

Key Considerations for Patient-Reported Outcome Measures

Bill of Health

PROM responses can be used for purposes of clinical care, research, quality improvement, Food and Drug Administration (FDA) approval of drugs and devices, and even insurance reimbursement. Medical malpractice could occur for two reasons.

article thumbnail

Understanding the FDA Debarment List

Compliancy Group

One primary aspect of compliance is ensuring you are checking the FDA debarment list to verify that those involved in your operations aren’t essentially banned from working in the drug industry. The purpose of this list is to help businesses stay within compliance with FDA regulations and to safeguard public health.

FDA 52